Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Jinping Zheng, Jianyong Zhang, Xiuhua Fu, Changqing Lin, Xinri Zhang, Xiaodong Mei, Massimo Corradi, Glauco Cappellini, Emanuele Calabro, Cissy Zhu & Eva Topole. (2023) Comparison of extrafine beclomethasone dipropionate/formoterol fumarate dry powder inhaler and pressurized metered-dose inhaler in Chinese patients with asthma: the FORTUNE study. Journal of Asthma 0:0, pages 1-8.
Read now
Read now
Kai-Michael Beeh, Piotr Kuna, Massimo Corradi, Isabelle Viaud, Alessandro Guasconi & George Georges. (2021) Comparison of Dry-Powder Inhaler and Pressurized Metered-Dose Inhaler Formulations of Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium in Patients with COPD: The TRI-D Randomized Controlled Trial. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 79-89.
Read now
Read now
Khushboo Patel, Chellampillai Bothiraja, Ashwin Mali & Ravindra Kamble. (2021) Investigation of sorafenib tosylate loaded liposomal dry powder inhaler for the treatment of non-small cell lung cancer. Particulate Science and Technology 39:8, pages 990-999.
Read now
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Read now
Omar S Usmani. (2019) Choosing the right inhaler for your asthma or COPD patient. Therapeutics and Clinical Risk Management 15, pages 461-472.
Read now
Read now
Jana Kozáková, Ayça Altay, Vladimír Ždímal, Ludmila Mašková, Fabio Sonvico, Eride Quarta, Alessandra Rossi, Francesca Buttini & Gaia Colombo. (2019) Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Drug Development and Industrial Pharmacy 45:10, pages 1664-1673.
Read now
Read now
Edit Benke, Árpád Farkas, Imre Balásházy, Piroska Szabó-Révész & Rita Ambrus. (2019) Stability test of novel combined formulated dry powder inhalation system containing antibiotic: physical characterization and in vitro–in silico lung deposition results. Drug Development and Industrial Pharmacy 45:8, pages 1369-1378.
Read now
Read now
Piyush Mehta, C. Bothiraja, Shivajirao Kadam & Atmaram Pawar. (2018) Potential of dry powder inhalers for tuberculosis therapy: facts, fidelity and future. Artificial Cells, Nanomedicine, and Biotechnology 46:sup3, pages S791-S806.
Read now
Read now
Nashwa Osman, Kan Kaneko, Valeria Carini & Imran Saleem. (2018) Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies. Expert Opinion on Drug Delivery 15:8, pages 821-834.
Read now
Read now
Michael DePietro, Ileen Gilbert, Lauren A. Millette & Michael Riebe. (2018) Inhalation device options for the management of chronic obstructive pulmonary disease. Postgraduate Medicine 130:1, pages 83-97.
Read now
Read now
Abdelwahab Omri. (2015) Pulmonary drug and vaccine delivery: therapeutic significance and major challenges. Expert Opinion on Drug Delivery 12:6, pages 853-855.
Read now
Read now
Articles from other publishers (49)
SURAJ CHOUDHARY & APARAJITA PATIL. (2023) AMELIORATION IN APPROACHES FOR ENHANCED PULMONARY DRUG DELIVERY. Asian Journal of Pharmaceutical and Clinical Research, pages 18-29.
Crossref
Crossref
Bo Wang, Jia Xiang, Binsheng He, Songwen Tan & Wenhu Zhou. (2023) Enhancing bioavailability of natural extracts for nutritional applications through dry powder inhalers (DPI) spray drying: technological advancements and future directions. Frontiers in Nutrition 10.
Crossref
Crossref
Yongyi Peng, Zhongping Wu, Kuiqing Lin, Ruibo Huang, Jinhai Huang, Junfeng Lin, Shubing Chen, Jinping Zheng & Yi Gao. (2023) Exploration of quality criteria for the detection of peak inspiratory flow under different resistance conditions. Technology and Health Care, pages 1-10.
Crossref
Crossref
Nianxia Sun, Min Zhang, Wentao Zhu, Pingping Song, Tingting Dai, Peng Huang, Zhili Han & Dianlei Wang. (2023) Allyl isothiocyanate dry powder inhaler based on cyclodextrin-metal organic frameworks for pulmonary delivery. iScience 26:1, pages 105910.
Crossref
Crossref
Piyush Pradeep Mehta & Prakash Dilip Jadhav. 2023. Green Sustainable Process for Chemical and Environmental Engineering and Science. Green Sustainable Process for Chemical and Environmental Engineering and Science
131
186
.
Tomomi Akita, Yuki Morita, Takehiro Kawai, Kazuaki Oda, Kota Tange, Yuta Nakai & Chikamasa Yamashita. (2022) Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema. Pharmaceutics 15:1, pages 37.
Crossref
Crossref
Basanth Babu Eedara, Rakesh Bastola & Shyamal C. Das. (2022) Dissolution and Absorption of Inhaled Drug Particles in the Lungs. Pharmaceutics 14:12, pages 2667.
Crossref
Crossref
Tarun Virmani, Girish Kumar, Reshu Virmani, Ashwani Sharma & Kamla Pathak. (2022) Nanocarrier-based approaches to combat chronic obstructive pulmonary disease. Nanomedicine 17:24, pages 1833-1854.
Crossref
Crossref
Riya Mahar, Arpita Chakraborty & Nidhi Nainwal. (2022) The influence of carrier type, physical characteristics, and blending techniques on the performance of dry powder inhalers. Journal of Drug Delivery Science and Technology 76, pages 103759.
Crossref
Crossref
Gerald A. Hebbink, Maarten Jaspers, Harry J.W. Peters & Bastiaan H.J. Dickhoff. (2022) Recent developments in lactose blend formulations for carrier-based dry powder inhalation. Advanced Drug Delivery Reviews 189, pages 114527.
Crossref
Crossref
Nashwa El-Gendy, Craig M. Bertha, Mohammed Abd El-Shafy, Dhaval K. Gaglani, Andrew Babiskin, Elizabeth Bielski, Susan Boc, Sneha Dhapare, Lanyan Fang, Katharine Feibus, Anubhav Kaviratna, Bing V. Li, Markham C. Luke, Tian Ma, Bryan Newman, Michael Spagnola, Ross L. Walenga & Liang Zhao. (2022) Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective. Advanced Drug Delivery Reviews 189, pages 114519.
Crossref
Crossref
Tushar Saha, Miguel E. Quiñones-Mateu & Shyamal C. Das. (2022) Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices. International Journal of Pharmaceutics 624, pages 122042.
Crossref
Crossref
BARTŁOMIEJ ROSPOND, AGATA KRAKOWSKA, BOŻENA MUSZYŃSKA & WŁODZIMIERZ OPOKA. (2022) The history, current state and perspectives of aerosol therapy. Acta Pharmaceutica 72:2, pages 225-243.
Crossref
Crossref
Yuqing Ye, Ying Ma & Jesse Zhu. (2022) The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?. International Journal of Pharmaceutics 614, pages 121457.
Crossref
Crossref
M. Matuszak, M. Ochowiak, S. Włodarczak, A. Krupińska & M. Doligalski. (2022) State-of-the-art review of the application and development of various methods of aerosol therapy. International Journal of Pharmaceutics 614, pages 121432.
Crossref
Crossref
Ratnali Bania, Pobitra Borah, Juti Rani Devi, Satyendra Deka, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb, Katharigatta N. Venugopala & Gaurav Gupta. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
45
73
.
Chandrakantsing V. Pardeshi, Sagar R. Pardeshi & Jitendra B. Naik. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases
219
258
.
Priya Muralidharan, Don HayesJr.Jr., Jeffrey R. Fineman, Stephen M. Black & Heidi M. Mansour. (2021) Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery. Pharmaceutics 13:12, pages 2188.
Crossref
Crossref
Paraskevi Kyriaki Monou, Eleftherios G. Andriotis, Nikolaos Bouropoulos, Emmanuel Panteris, Melpomeni Akrivou, Ioannis S. Vizirianakis, Zeeshan Ahmad & Dimitrios G. Fatouros. (2021) Engineered mucoadhesive microparticles of formoterol/budesonide for pulmonary administration. European Journal of Pharmaceutical Sciences 165, pages 105955.
Crossref
Crossref
Li Ding, Ashlee D. Brunaugh, Sven Stegemann, Scott V. Jermain, Matthew J. Herpin, Justin Kalafat & Hugh D. C. Smyth. (2021) A Quality by Design Framework for Capsule-Based Dry Powder Inhalers. Pharmaceutics 13:8, pages 1213.
Crossref
Crossref
Ayça Altay Benetti, Annalisa Bianchera, Francesca Buttini, Laura Bertocchi & Ruggero Bettini. (2021) Mannitol Polymorphs as Carrier in DPIs Formulations: Isolation Characterization and Performance. Pharmaceutics 13:8, pages 1113.
Crossref
Crossref
Priya Muralidharan, Maria F. Acosta, Alexan I. Gomez, Carissa Grijalva, Haiyang Tang, Jason X.-J. Yuan & Heidi M. Mansour. (2021) Design and Comprehensive Characterization of Tetramethylpyrazine (TMP) for Targeted Lung Delivery as Inhalation Aerosols in Pulmonary Hypertension (PH): In Vitro Human Lung Cell Culture and In Vivo Efficacy. Antioxidants 10:3, pages 427.
Crossref
Crossref
Maria F. Acosta, Michael D. Abrahamson, David Encinas-Basurto, Jeffrey R. Fineman, Stephen M. Black & Heidi M. Mansour. (2020) Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers. The AAPS Journal 23:1.
Crossref
Crossref
Maria F. Acosta, Priya Muralidharan, Carissa L. Grijalva, Michael D. Abrahamson, Don HayesJr.Jr., Jeffrey R. Fineman, Stephen M. Black & Heidi M. Mansour. (2021)
Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,
in vitro
2D/3D human lung cell cultures, and
in vivo
efficacy
. Therapeutic Advances in Respiratory Disease 15, pages 175346662199824.
Crossref
Crossref
James F. Donohue, Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann & Glenn D. Crater. (2020) Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Maria F. Acosta, Priya Muralidhran, Michael D. Abrahamson, Carissa L. Grijalva, Megan Carver, Haiyang Tang, Christina Klinger, Jeffrey R. Fineman, Stephen M. Black & Heidi M. Mansour. (2020) Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH. Pulmonary Pharmacology & Therapeutics 65, pages 101998.
Crossref
Crossref
Stefano Focaroli, Guannan Jiang, Peter O'Connell, John V. Fahy & Anne-Marie Healy. (2020) The Use of a Three-Fluid Atomising Nozzle in the Production of Spray-Dried Theophylline/Salbutamol Sulphate Powders Intended for Pulmonary Delivery. Pharmaceutics 12:11, pages 1116.
Crossref
Crossref
Priya Muralidharan, Evan K. Mallory, Monica Malapit, Hanna Phan, Julie G. Ledford, Don Hayes & Heidi M. Mansour. (2020) Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols. RSC Advances 10:68, pages 41846-41856.
Crossref
Crossref
Valéria Maria de Oliveira Cardoso, Bruna Juliana Moreira, Edson José Comparetti, Isabella Sampaio, Leonardo Miziara Barboza Ferreira, Paula Maria Pincela Lins & Valtencir Zucolotto. (2020) Is Nanotechnology Helping in the Fight Against COVID-19?. Frontiers in Nanotechnology 2.
Crossref
Crossref
Guihong Chai, Amr Hassan, Tuo Meng, Lihua Lou, Jonathan Ma, Russell Simmers, Lei Zhou, Bruce K. Rubin, Qi (Tony) Zhou, P. Worth Longest, Michael Hindle & Qingguo Xu. (2020) Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery. Nanomedicine: Nanotechnology, Biology and Medicine 29, pages 102262.
Crossref
Crossref
Chris N. Barnes, Donald A. Mahler, Jill A. Ohar, David A. Lombardi & Glenn D. Crater. (2020) Peak Inspiratory Flows. Chest 158:4, pages 1413-1419.
Crossref
Crossref
Khaled AboulFotouh, Yi Zhang, Mohammed Maniruzzaman, Robert O. WilliamsIIIIII & Zhengrong Cui. (2020) Amorphous solid dispersion dry powder for pulmonary drug delivery: Advantages and challenges. International Journal of Pharmaceutics 587, pages 119711.
Crossref
Crossref
Piyush P. Mehta, Shivajirao S. Kadam & Atmaram P. Pawar. (2020) Effect of USP induction ports and modified glass sampling apparatus on aerosolization performance of lactose carrier-based fluticasone propionate dry powder inhaler. Journal of Drug Delivery Science and Technology 58, pages 101794.
Crossref
Crossref
Xuejuan Zhang, Yingtong Cui, Ruifeng Liang, Guanlin Wang, Xiao Yue, Ziyu Zhao, Zhengwei Huang, Ying Huang, Jianfang Geng, Xin Pan & Chuanbin Wu. (2020) Novel approach for real-time monitoring of carrier-based DPIs delivery process via pulmonary route based on modular modified Sympatec HELOS. Acta Pharmaceutica Sinica B 10:7, pages 1331-1346.
Crossref
Crossref
Piyush P. Mehta, Shivajirao S. Kadam & Atmaram P. Pawar. (2020) Influence of modified induction port, modified DUSA assembly and device air-inlet geometry on the aerosolization pattern of a dry powder inhaler. Journal of Drug Delivery Science and Technology 55, pages 101416.
Crossref
Crossref
Lauren Hartsell Crump, Miranda Benfield, Caleb Ramey, Ashley Arcara, Sebin Yang, Jenna Brown, Geoffrey Mospan & Cortney Mospan. (2019) Drug updates and approvals. The Nurse Practitioner 44:12, pages 21-32.
Crossref
Crossref
Golshan Bagherisadeghi, Henry Chrystyn, Mohamad Abadelah & El Hassane Larhrib. (2019) Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease. European Journal of Pharmaceutical Sciences 139, pages 105059.
Crossref
Crossref
Jingya Wu, Lan Wu, Feng Wan, Jukka Rantanen, Dongmei Cun & Mingshi Yang. (2019) Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders. International Journal of Pharmaceutics 566, pages 32-39.
Crossref
Crossref
Mohamad Abadelah, Henry Chrystyn & Hassan Larhrib. (2019) Use of inspiratory profiles from patients with chronic obstructive pulmonary disease (COPD) to investigate drug delivery uniformity and aerodynamic dose emission of indacaterol from a capsule based dry powder inhaler. European Journal of Pharmaceutical Sciences 134, pages 138-144.
Crossref
Crossref
Sitaram P. Velaga, Jelena Djuris, Sandra Cvijic, Stavroula Rozou, Paola Russo, Gaia Colombo & Alessandra Rossi. (2018) Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products. European Journal of Pharmaceutical Sciences 113, pages 18-28.
Crossref
Crossref
Piyush Mehta. (2018) Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering. Journal of Drug Delivery 2018, pages 1-19.
Crossref
Crossref
Ayah Shakshuki & Remigius U. Agu. (2017) Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease. Pulmonary Therapy 3:2, pages 267-281.
Crossref
Crossref
Miao Li, Tongtong Zhang, Lifei Zhu, Rui Wang & Yiguang Jin. (2017) Liposomal andrographolide dry powder inhalers for treatment of bacterial pneumonia via anti-inflammatory pathway. International Journal of Pharmaceutics 528:1-2, pages 163-171.
Crossref
Crossref
Romain Merlos, Nathalie Wauthoz, Vincent Levet, Laure Belhassan, Thami Sebti, Francis Vanderbist & Karim Amighi. (2017) Optimization and scaling-up of ITZ-based dry powders for inhalation. Journal of Drug Delivery Science and Technology 37, pages 147-157.
Crossref
Crossref
Elena Fernández Fernández, Nadine Bangel-Ruland, Katja Tomczak & Wolf-Michael Weber. (2016) Optimization of CFTR-mRNA transfection in human nasal epithelial cells. Translational Medicine Communications 1:1.
Crossref
Crossref
. 2016. Drug Delivery. Drug Delivery
249
277
.
Teresa Jong, Jian Li, David A.V. Morton, Qi (Tony) Zhou & Ian Larson. (2016) Investigation of the Changes in Aerosolization Behavior Between the Jet-Milled and Spray-Dried Colistin Powders Through Surface Energy Characterization. Journal of Pharmaceutical Sciences 105:3, pages 1156-1163.
Crossref
Crossref
Priya Muralidharan, Don Hayes, Stephen M. Black & Heidi M. Mansour. (2016) Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway. Molecular Systems Design & Engineering 1:1, pages 48-65.
Crossref
Crossref
Shuguang Hou, Jiangyue Wu, Xu Li & Hong Shu. (2015) Practical, regulatory and clinical considerations for development of inhalation drug products. Asian Journal of Pharmaceutical Sciences 10:6, pages 490-500.
Crossref
Crossref